Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination.
Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes.
Promoting remyelination for the treatment of multiple sclerosis: opportunities and challenges.
Resident glial cell activation in response to perispinal inflammation leads to acute changes in nociceptive sensitivity: implications for the generation of neuropathic pain.
Experiences of hospitalization in patients with multiple sclerosis: A qualitative study.
Epilepsy surgery outcome in temporal lobe cavernoma and multiple sclerosis.
Neurodegeneration in multiple sclerosis: novel treatment strategies.
Oxidative stress and neurodegenerative disease.
Idiopathic inflammatory demyelinating diseases of the brainstem.
Isoprostanes and Neuroprostanes as Biomarkers of Oxidative Stress in Neurodegenerative Diseases.
Class II HLA interactions modulate genetic risk for multiple sclerosis.
Suppression of IL-10 production by calcitriol in patients with multiple sclerosis.
Evaluation of the implication of KIR2DL2 receptor in multiple sclerosis and herpesvirus susceptibility.
Functional organization of an Mbp enhancer exposes striking transcriptional regulatory diversity within myelinating glia.
FTY720 induces apoptosis of m2 subtype acute myeloid leukemia cells by targeting sphingolipid metabolism and increasing endogenous ceramide levels.
In vivo imaging of system xc- as a novel approach to monitor multiple sclerosis.
Difficulties with emotion regulation in multiple sclerosis: Links to executive function, mood, and quality of life.
Repeated measurement of the attention components of patients with multiple sclerosis using the Attention Network Test-Interaction (ANT-I): Stability, isolability, robustness, and reliability.
Newly produced T and B lymphocytes and T-cell receptor repertoire diversity are reduced in peripheral blood of fingolimod-treated multiple sclerosis patients.
Identification of suitable reference genes for peripheral blood mononuclear cell subset studies in multiple sclerosis.
Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.
Fibronectin aggregation in multiple sclerosis lesions impairs remyelination.
The Interdependent, Overlapping, and Differential Roles of Type I and II IFNs in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Vitamin D in multiple sclerosis: implications for assessment and treatment.
Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
Pages
« first
‹ previous
…
354
355
356
357
358
359
360
361
362
…
next ›
last »